INTERNATIONAL PATENT: MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT FILES APPLICATION FOR "A NUCLEIC ACID ENCODING A CD8 ALPHA BETA CO-RECEPTOR, CELLS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME"

GENEVA, Feb. 10 -- MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (Robert-Rossle-Str. 1013125 Berlin) filed a patent application (PCT/EP2024/071763) for "A NUCLEIC ACID ENCODING A CD8 ALPHA BETA CO-RECEPTOR, CELLS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME" on Aug 01, 2024. With publication no. WO/2025/027111, the details related to the patent application was published on Feb 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LORENZ, Felix (Gartenstr. 713129 Berlin), CLAUSS, Julian (Goyastr. 613086 Berlin), EDES, Inan (Pasewalkerstr. 1813127 Berlin), STAH...